Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 13, 1124 (2007)
doi:10.1038/nm1007-1124a
Poor trial design leaves gene therapy death a mystery
Meredith Wadman1
- Washington, DC
The gene therapy trial during which a 36-year-old Illinois woman died in July was inappropriately designed, experts said at the 17 September meeting of the government panel investigating her death.Researchers affiliated with Seattle-based Targeted Genetics injected a gene therapy treatment into Jolee Mohr's right knee first in February and again on 2 July.
To read this story in full you will need to login or make a payment (see right).
